RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Meropenem

Complicated skin and skin structure infections, Complicated intra-abdominal infections, Bacterial meningitis

Indications

  • Complicated skin and skin structure infections
  • Complicated intra-abdominal infections
  • Bacterial meningitis

Adult dosing

  • csssi: dose: 500; unit: mg; route: IV; interval: every 8 hours; fixed: true; labelExcerpt: 500 mg every 8 hours by intravenous infusion over 15 to 30 minutes for complicated skin and skin structure infections (cSSSI) for adult patients.
  • csssi pseudomonas: dose: 1; unit: g; route: IV; interval: every 8 hours; fixed: true; labelExcerpt: When treating infections caused by Pseudomonas aeruginosa , a dose of 1 gram every 8 hours is recommended.
  • intra abdominal: dose: 1; unit: g; route: IV; interval: every 8 hours; fixed: true; labelExcerpt: 1 gram every 8 hours by intravenous infusion over 15 minutes to 30 minutes for intra-abdominal infections for adult patients.

Pediatric dosing

  • csssi: dose: 10; unit: mg/kg; route: IV; interval: every 8 hours; weightBased: true; maxDose: 500; maxDoseAbsolute: true; labelExcerpt: Complicated skin and skin structure* 10 500 mg Every 8 hours

Renal adjustment

  • mild: Recommended dose Every 12 hours; moderate: Recommended dose Every 12 hours; severe: One-half recommended dose Every 12 hours; failure: One-half recommended dose Every 24 hours; note: CrCl >50: q8h; 26-50: q12h; 10-25: 1/2 dose q12h; <10: 1/2 dose q24h Label: "Creatinine Clearance (mL/min) Dose (dependent on type of infection) Dosing Interval Greater than 50 Recommended dose (500 mg cSSSI and 1 gram Intra-abdominal) Every 8 hours 26-50 Recommended dose Every 12 hours 10-25 One-half recommended dose Every 12 hours Le"

Hepatic adjustment

  • No dosage adjustment necessary.

Contraindications

  • Known hypersensitivity to any component
  • Anaphylactic reactions to beta-lactams

Clinical pearls

  • Co-administration with valproic acid reduces valproic acid levels and increases risk of breakthrough seizures.
  • Monitor for C. difficile-associated diarrhea.
  • Severe hypersensitivity reactions including anaphylaxis can occur; confirm allergy history before use.
  • Discard reconstituted solutions that are not used immediately, though storage limits exist for specific conditions.

Source and review

  • DailyMed label (meropenem), Set ID 31dd2160-7dbd-51fa-e054-00144ff88e88, effective 2026-11-02. Last reviewed: 2026-11-11